Jan. 11, 2020

I recently had our intern Nour Salhab, Pharm.D. Candidate, USF College of Pharmacy, take a look at the latest information comparing DPP-4 inhibitors with SGLT-2 inhibitors. I had asked her to see if there was enough evidence to cause you, our readers, to choose one over the other.

She delivered on that request with a comparison article and then went the extra step: that not only did they do a better job for cardiovascular patients, they actually saved health plans and patients money.

 

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief